Gionata Fiorino to Clinical Trials as Topic
This is a "connection" page, showing publications Gionata Fiorino has written about Clinical Trials as Topic.
Connection Strength
0.034
-
Vedolizumab for the treatment of inflammatory bowel diseases: from symptomatic control to mucosal healing. Immunotherapy. 2019 05; 11(7):565-575.
Score: 0.012
-
Vedolizumab for the treatment of Crohn's disease. Expert Rev Clin Immunol. 2018 03; 14(3):179-189.
Score: 0.011
-
Early intervention in Crohn's disease: towards disease modification trials. Gut. 2017 12; 66(12):2179-2187.
Score: 0.011